
The Omics and Computational Biology Group focuses on understanding the molecular mechanisms of biological systems in depth using genomic, proteomic, and other omics data. Pathways regulating cancer progression and cell plasticity are comprehensively examined through computational modeling and AI-assisted approaches. The group contributes to the development of biomarkers and therapeutic targets, ensuring effective integration between fundamental biological knowledge and translational applications.